Beactica's Unattributed Round

Beactica raised a round of funding on November 22, 2017. Investors include Vinnova.

Beactica is a specialist drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. As well as progressing its o…

Articles about Beactica's Unattributed Round: